Sort
326,823 grants matching “clinical trial”
Activation of Plasmacytoid Dendritic Cells (pDCs) to Induce Antitumor Activity
$1,752,897Patrick Hwu · University Of Tx Md Anderson Can Ctr · P01 · FY2009 · CA
PROTECT (Harnessing PROTEin degradation for Advanced Childhood Tumors)
$1,752,813Kimberly Stegmaier · Dana-Farber Cancer Inst · OT2 · FY2025 · CA
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$1,752,798Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2024 · AI
Development of Nogo Receptor Decoy for the Treatment of Spinal Cord Injury
$1,752,658Asaf Alimardanov · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Prostate Cancer Imaging
$1,752,655Peter L. Choyke · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Noninvasive Biomarkers to Advance Emerging DBS Electrode Technologies in Parkinson's Disease
$1,752,624Harrison Carroll Walker · University Of Alabama At Birmingham · UH3 · FY2019 · NS
ADULT AIDS CLINICAL TRIALS UNIT
$1,752,570Case Western Reserve University · U01 · FY2000 · AI
Developing Efficient and Safe Gene Transfer to Primate Hematopoietic Stem Cells
$1,752,245Cynthia E Dunbar · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL
Production of Aluminum Based Adjuvants
$1,752,200Fred Mack · Advanced Bioscience Laboratories, Inc. · N01 · FY2017 · AI
Washington University Human Tumor Atlas Research Center
$1,752,191Li Ding · Washington University · U2C · FY2018 · CA
Development of Apo Mimetic Peptides for the Treatment Cardiovascular Disease
$1,752,138Alan Remaley · National Heart, Lung, And Blood Institute · ZIA · FY2017 · HL
Translational Coordination and Dissemination Center for the SCGE Consortium
$1,752,114Melinda R Dwinell · Medical College Of Wisconsin · U24 · FY2025 · HL
Translational Coordination and Dissemination Center for the SCGE Consortium
$1,752,114Melinda R Dwinell · Medical College Of Wisconsin · U24 · FY2024 · HL
Brain Imaging, APOE & the Preclinical Course of Alzheimer's Disease
$1,752,021Eric M Reiman · Banner Alzheimer'S Institute · R01 · FY2016 · AG
Harvard Clinical and Translational Science Center
$1,752,000Lee Marshall Nadler · Harvard Medical School · KL2 · FY2016 · TR
Small Molecule Inhibitors of Smallpox Virus Replication
$1,751,533Robert Jordan · Siga Technologies, Inc. · R44 · FY2007 · AI
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
$1,751,531James D Bearden · Spartanburg Regional Medical Center · U10 · FY2010 · CA
2/2 Ponce School of Medicine-Moffitt Cancer Center Partnership
$1,751,252Kenneth Lynn Wright · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2018 · CA
IL-2IL-15 Cytokine Receptor: Implications for Cancer Therapy and Vaccine Design
$1,751,169Thomas Waldmann · Division Of Clinical Sciences - Nci · ZIA · FY2011 · CA
Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy
$1,751,169Thomas Waldmann · Division Of Basic Sciences - Nci · ZIB · FY2011 · CA
California-Mexico-Puerto Rico Partnership (CAMPO) Center for Prevention of HPV-related Cancer in HIV+ Populations
$1,751,091Joel Palefsky · University Of California, San Francisco · U54 · FY2021 · CA
Novel Systemic Delivery of Peptide-Mediated Anti-Sense Oligonucleotides for Dementia with Lewy Bodies
$1,751,085Robert A Rissman · University Of California, San Diego · RF1 · FY2021 · AG
University of Washington Arboviral Research Network (UWARN)
$1,751,002Wesley C Van Voorhis · University Of Washington · U01 · FY2020 · AI
Safety and tolerability testing of VU0467319: an M1 PAM for clinical development
$1,750,895Craig Lindsley · Vanderbilt University · U19 · FY2016 · MH
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$1,750,860Gordon R. Bernard · Vanderbilt University · UL1 · FY2008 · RR